Valuation: Slottsviken Fastighetsaktiebolag (publ)

Market Cap 52M 5.39M 4.72M 4.35M 4.02M 7.63M 514M 7.76M 20.42M 253M 20.25M 19.81M 871M P/E 2024
23.1x
P/E 2025 28.8x
Enterprise Value 103M 10.7M 9.36M 8.64M 7.98M 15.14M 1.02B 15.39M 40.52M 503M 40.19M 39.32M 1.73B EV / Sales 2024
8.35x
EV / Sales 2025 9.69x
Free-Float
83.79%
Yield 2024
0.3%
Yield 2025 0.3%
Manager TitleAgeSince
Chief Executive Officer 47 2012-12-31
Director TitleAgeSince
Chairman 49 2012-12-31
Director/Board Member 47 2012-12-31
Chairman 51 2012-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+2.43%+2.34%+33.03%+26.14% 42.6B
-0.43%-0.85%+53.50%+144.24% 31.1B
+1.71%+3.41%+6.91%+2.32% 28.79B
0.00%-2.15%-15.29%+73.39% 28.54B
-0.72%-1.88%+9.81%+62.53% 25.23B
0.00%-2.07%-34.34%-60.23% 21.92B
-0.87%-2.21%+35.96%+110.76% 21.59B
+1.56%+2.66%+30.82%+7.73% 19.99B
+2.95%+3.12%-7.65%-21.47% 17.51B
Average +0.74%+1.48%+12.53%+38.38% 26.36B
Weighted average by Cap. +0.78%+1.52%+15.12%+42.94%

Financials

2024 2025
Net sales 13.08M 1.36M 1.19M 1.09M 1.01M 1.92M 129M 1.95M 5.14M 63.74M 5.09M 4.98M 219M 13.53M 1.4M 1.23M 1.13M 1.05M 1.99M 134M 2.02M 5.31M 65.96M 5.27M 5.16M 227M
Net income 2.78M 288K 252K 233K 215K 408K 27.51M 415K 1.09M 13.55M 1.08M 1.06M 46.6M 2.78M 289K 252K 233K 215K 408K 27.52M 415K 1.09M 13.56M 1.08M 1.06M 46.61M
Net Debt 41.65M 4.32M 3.78M 3.49M 3.22M 6.11M 412M 6.21M 16.35M 203M 16.22M 15.87M 698M 51.19M 5.31M 4.64M 4.28M 3.96M 7.51M 506M 7.63M 20.1M 250M 19.94M 19.5M 858M
Logo Slottsviken Fastighetsaktiebolag (publ)
Slottsviken Fastighetsaktiebolag (publ), formerly Conpharm AB (publ), is a Sweden-based company involved in real estate sector. The Company owns and manages residential, office and commercial properties in peri-urban locations. Slottsviken Fastighetsaktiebolag (publ) is a real estate company that acquires, manages and develops attractive properties in urban areas with a focus on the Gothenburg region. Its property portfolio includes residential properties; and commercial premises for production, shop/trade, restaurants, industry, workshops, logistics, and offices. The company also invests in securities; and owns and manages intellectual property rights relating to Reumacon and Wartec life science activities.
Employees
-